BACKGROUND: Access to antiretroviral therapy (ART) has increased dramatically in resource-limited settings since its introduction a decade ago. However, ART coverage remains low in countries with the highest disease burden, which may be partially explained by poor testing to care linkages. HIV testing service may impact early attrition in the HIV treatment cascade. METHODS: A retrospective cohort study was conducted in 18 clinics in central Mozambique using routine patient data and monthly reports. Patients referred from voluntary counseling and testing (VCT) were compared with those referred from prevention of mother-to-child transmission (PMTCT) for 3 outcomes: (1) enrollment at an HIV clinic ≤30 days after testing HIV positive, (2) CD4 test ≤30 days after enrollment, and (3) ART initiation ≤90 days after first CD4 test. RESULTS: Patient retention in the HIV care system dropped at each step from HIV testing to ART initiation. Enrollment in HIV care was not significantly different between PMTCT and VCT [risk ratio (RR) = 0.84, 0.72 < RR < 1.02]. Women tested in PMTCT were less likely to have a CD4 test ≤30 days after enrollment when adjusting for age, education level, and marital status (adjusted RR = 0.84, 0.70 < RR < 1.00), and were less likely to initiate ART ≤90 days after their first CD4 test when adjusting for age, education, and marital status (adjusted RR = 0.56, 0.44 < RR < 0.71). CONCLUSIONS: Poor linkages between HIV testing and care hamper efforts to improve coverage for HIV care and treatment services. Increased loss to follow-up among women diagnosed in PMTCT relative to VCT is worrisome and merits further qualitative research and programmatic attention.
BACKGROUND: Access to antiretroviral therapy (ART) has increased dramatically in resource-limited settings since its introduction a decade ago. However, ART coverage remains low in countries with the highest disease burden, which may be partially explained by poor testing to care linkages. HIV testing service may impact early attrition in the HIV treatment cascade. METHODS: A retrospective cohort study was conducted in 18 clinics in central Mozambique using routine patient data and monthly reports. Patients referred from voluntary counseling and testing (VCT) were compared with those referred from prevention of mother-to-child transmission (PMTCT) for 3 outcomes: (1) enrollment at an HIV clinic ≤30 days after testing HIV positive, (2) CD4 test ≤30 days after enrollment, and (3) ART initiation ≤90 days after first CD4 test. RESULTS:Patient retention in the HIV care system dropped at each step from HIV testing to ART initiation. Enrollment in HIV care was not significantly different between PMTCT and VCT [risk ratio (RR) = 0.84, 0.72 < RR < 1.02]. Women tested in PMTCT were less likely to have a CD4 test ≤30 days after enrollment when adjusting for age, education level, and marital status (adjusted RR = 0.84, 0.70 < RR < 1.00), and were less likely to initiate ART ≤90 days after their first CD4 test when adjusting for age, education, and marital status (adjusted RR = 0.56, 0.44 < RR < 0.71). CONCLUSIONS: Poor linkages between HIV testing and care hamper efforts to improve coverage for HIV care and treatment services. Increased loss to follow-up among women diagnosed in PMTCT relative to VCT is worrisome and merits further qualitative research and programmatic attention.
Authors: L D Bwirire; M Fitzgerald; R Zachariah; V Chikafa; M Massaquoi; M Moens; K Kamoto; E J Schouten Journal: Trans R Soc Trop Med Hyg Date: 2008-05-16 Impact factor: 2.184
Authors: Abigail M Hatcher; Janet M Turan; Hannah H Leslie; Lucy W Kanya; Zachary Kwena; Malory O Johnson; Starley B Shade; Elizabeth A Bukusi; Alexandre Doyen; Craig R Cohen Journal: AIDS Behav Date: 2012-07
Authors: Bingxia Wang; Elena Losina; Ruth Stark; Alison Munro; Rochelle P Walensky; Marisa Wilke; Des Martin; Zhigang Lu; Kenneth A Freedberg; Robin Wood Journal: S Afr Med J Date: 2011-04
Authors: T D Moon; J R Burlison; M Blevins; B E Shepherd; A Baptista; M Sidat; A E Vergara; S H Vermund Journal: Int J STD AIDS Date: 2011-11 Impact factor: 1.359
Authors: Elena Losina; Ingrid V Bassett; Janet Giddy; Senica Chetty; Susan Regan; Rochelle P Walensky; Douglas Ross; Callie A Scott; Lauren M Uhler; Jeffrey N Katz; Helga Holst; Kenneth A Freedberg Journal: PLoS One Date: 2010-03-04 Impact factor: 3.240
Authors: Katharina Kranzer; Jennifer Zeinecker; Philip Ginsberg; Catherine Orrell; Nosindiso N Kalawe; Stephen D Lawn; Linda-Gail Bekker; Robin Wood Journal: PLoS One Date: 2010-11-02 Impact factor: 3.240
Authors: Barrot H Lambdin; Mark A Micek; Thomas D Koepsell; James P Hughes; Kenneth Sherr; James Pfeiffer; Marina Karagianis; Joseph Lara; Stephen S Gloyd; Andy Stergachis Journal: BMC Health Serv Res Date: 2012-02-02 Impact factor: 2.655
Authors: Manuel Napúa; James T Pfeiffer; Falume Chale; Roxanne Hoek; Joao Manuel; Cathy Michel; Jessica G Cowan; James F Cowan; Sarah Gimbel; Kenneth Sherr; Stephen Gloyd; Rachel R Chapman Journal: J Acquir Immune Defic Syndr Date: 2016-08-01 Impact factor: 3.731
Authors: Jacob Bor; Matthew P Fox; Sydney Rosen; Atheendar Venkataramani; Frank Tanser; Deenan Pillay; Till Bärnighausen Journal: PLoS Med Date: 2017-11-28 Impact factor: 11.613
Authors: Erica Samson Sanga; Wondwossen Lerebo; Adiel K Mushi; Petra Clowes; Willyhelmina Olomi; Leonard Maboko; Christina Zarowsky Journal: BMJ Open Date: 2017-04-12 Impact factor: 2.692
Authors: Erica S Sanga; Ferdinand C Mukumbang; Adiel K Mushi; Willyhelmina Olomi; Wondwossen Lerebo; Christina Zarowsky Journal: AIDS Res Ther Date: 2018-11-20 Impact factor: 2.250